This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Getting Ready to Pay Bigger Dividends

CVS Caremark

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One billion: that's how many prescriptions pharmacy giant CVS Caremark (CVS - Get Report) fills each year. There's safety in those numbers, at least for CVS shareholders. The firm has consistently outperformed its pure-play retail pharmacy peers, delivering enviable net profit margins and paying out a decent dividend throughout the financial roller coaster of 2007 and 2008. But CVS' income statement has grown faster than its dividend payout has -- and I think that the firm is ready to hike its 16.25-cent quarterly dividend.

>>5 Big Stock Charts You've Got to See to Believe

While CVS is best known to consumers for some 7,000 namesake retail pharmacies, the other part of the company's name comes from the 2007 acquisition of Caremark, a pharmacy benefit manager. Buying Caremark was a big deal for CVS -- it meant that the firm could suddenly avoid the somewhat adversarial relationship between PBMs and retail pharmacies. In essence, PBMs act as a middleman for pharmacies, stepping in between drugstores and drugmakers to source, package, and distribute pharmaceuticals in exchange for a markup along the way. Because CVS owns its own PBM, it doesn't have to fight over the size of that markup.

The introduction of MinuteClinics to many of CVS' store locations has provided another exciting growth avenue in the last few years, especially as consumers look for more cost-effective ways to get health treatments. Make no mistake: Right now, CVS' cash flows readily support a bigger dividend payout for investors.

CVS is one of Warren Buffett's holdings as of the most recently reported period.
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CVS $105.19 1.20%
EV $33.60 0.90%
GE $30.12 0.17%
VAL $106.88 -0.06%
DCI $32.24 -0.15%


Chart of I:DJI
DOW 17,699.78 +48.52 0.27%
S&P 500 2,055.71 +4.59 0.22%
NASDAQ 4,728.2490 +2.61 0.06%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs